CLOV insider plans sale of 85,704 shares

CLOV Class A common stock is scheduled to be sold through Morgan Stanley Smith Barney LLC, with up to 85,704 shares valued at $391,667.28 relative to 435,441,337 shares outstanding, targeting around 08/10/2026 on Nasdaq.

Rhea-AI Filing Summary

CLOV Class A common stock is scheduled to be sold through Morgan Stanley Smith Barney LLC, with up to 85,704 shares valued at $391,667.28 relative to 435,441,337 shares outstanding, targeting around 08/10/2026 on Nasdaq. These shares stem from Restricted Stock Units acquired as compensation on 08/08/2026. The disclosure also lists prior Rule 10b5-1 plan sales by Andrew Toy of 313,476 shares for $1,667,692.32 on 07/01/2026 and 62,711 shares for $292,860.37 on 07/15/2026.

Key Figures

Shares to be sold: 85,704 shares Aggregate value of planned sale: $391,667.28 Shares outstanding: 435,441,337 shares +3 more

6 metrics

Shares to be sold 85,704 shares Planned CLOV Class A common stock sale around 08/10/2026

Aggregate value of planned sale $391,667.28 Indicative value of 85,704 CLOV shares to be sold

Shares outstanding 435,441,337 shares CLOV Class A common stock outstanding as referenced in the notice

10b5-1 sale on 07/01/2026 313,476 shares for $1,667,692.32 CLOV Class A shares sold by Andrew Toy under 10b5-1 plan

10b5-1 sale on 07/15/2026 62,711 shares for $292,860.37 CLOV Class A shares sold by Andrew Toy under 10b5-1 plan

RSU acquisition date 08/08/2026 Date Restricted Stock Units in CLOV Class A common stock were acquired as compensation

Key Terms

Form 144, Restricted Stock Units, 10b5-1 Plan Sale

3 terms

Form 144 regulatory

"144: Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Units financial

"Class A Common Stock | 08/08/2026 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 Plan Sale regulatory

"10b5-1 Plan Sale Andrew Toy 1209 Orange Street Wilmington DE 19801"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock is covered in CLOV’s Form 144 notice?

The notice covers Class A Common Stock of CLOV, to be sold through Morgan Stanley Smith Barney LLC and listed for trading on Nasdaq around 08/10/2026.

How many CLOV shares are planned for sale under this Form 144?

The planned sale covers up to 85,704 shares of CLOV Class A common stock, with an indicated value of $391,667.28, compared with 435,441,337 shares outstanding.

What is the source of the CLOV shares to be sold?

The shares come from Restricted Stock Units in CLOV Class A common stock, acquired from the issuer on 08/08/2026 as compensation, and are now planned for sale following that acquisition.

What prior CLOV stock sales by Andrew Toy are disclosed?

Two prior Rule 10b5-1 plan sales by Andrew Toy are listed: 313,476 shares for $1,667,692.32 on 07/01/2026 and 62,711 shares for $292,860.37 on 07/15/2026.

What trading plan is referenced in the CLOV Form 144 activity?

The document references a 10b5-1 Plan Sale for the past three months’ transactions by Andrew Toy in CLOV Class A common stock, indicating trades executed under a pre-established trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/10/2026 - 04:29 PM Accepted by SEC EDGAR 08/10/2026 - 04:28 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001838733
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Clover Health Investments, Corp.
SEC File Number	001-39252
Address of Issuer	1209 Orange Street Wilmington DELAWARE 19801
Phone	2014322133
Name of Person for Whose Account the Securities are To Be Sold	Andrew Toy
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	Morgan Stanley Smith Barney LLC 1 New York Plaza 8th Floor New York NY 10004	85704	391667.28	435441337	08/10/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common Stock	08/08/2026	Restricted Stock Units	Issuer			85704	08/08/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Plan Sale Andrew Toy 1209 Orange Street Wilmington DE 19801	Class A Common Stock	07/15/2026	62711	292860.37
10b5-1 Plan Sale Andrew Toy 1209 Orange Street Wilmington DE 19801	Class A Common Stock	07/01/2026	313476	1667692.32

144: Remarks and Signature

Remarks	The proposed sales reported represent shares to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The purpose of the proposed sales is to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary transactions by the reporting person.
Date of Notice	08/10/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Peter J. Rivas as attorney-in-fact for Andrew Toy
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)